Latest news
October 30, 2025
Debiopharm Forges AI-Powered Alliance with NetTargets to Pioneer Dual-Payload ADCs Against Drug-Resistant Cancers
June 16, 2025
Debiopharm’s ADC Research Gains Momentum with Launch of First-In-Human Trial Assessing Debio 1562m in Acute Myeloid Leukemia Patients
April 22, 2025
Debiopharm to Reveal Insights from their ADC, DDR Inhibitor, and Antibody Conjugation Technology Research at The 2025 AACR Conference in…